NDAINJECTIONINJECTABLEPriority Review
Approved
May 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
GALLIUM CITRATE GA 67 (gallium citrate ga-67) by Lantheus Medical Imaging is clinical pharmacology gallium citrate ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. First approved in 1976.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Citrate Ga-67 is a radioactive diagnostic agent that concentrates in viable tumors and focal infection sites following intravenous injection. The mechanism of accumulation remains incompletely understood but involves lysosomal uptake and binding to intracellular proteins. It is used for diagnostic imaging to localize primary and metastatic tumors as well as sites of active infection.
LOE Approaching
LOE approaching trajectory suggests budget constraints and reduced team expansion; focus shifting to operational efficiency and compliance roles.
Mechanism of Action
CLINICAL PHARMACOLOGY Gallium Citrate Ga 67, with no carrier added, has been found to concentrate in certain viable primary and metastatic tumors as well as focal sites of infection. The mechanism of concentration is unknown, but investigational studies have shown that gallium Ga-67 accumulates in…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium Citrate Ga-67 places professionals in highly specialized quality, regulatory, and manufacturing roles within a mature diagnostic franchise. Career advancement opportunities are constrained by the LOE-approaching lifecycle, making this suitable for quality and compliance specialists seeking stable, technical positions rather than commercial growth roles.
Worked on GALLIUM CITRATE GA 67 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.